Alcon EBITDA Margin 2019-2025 | ALC
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Alcon (ALC) over the last 10 years. The current EBITDA margin for Alcon as of March 31, 2025 is .
| Alcon EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $9.93B | $2.61B | 26.31% |
| 2024-12-31 | $9.91B | $2.64B | 26.63% |
| 2024-09-30 | $9.76B | $2.45B | 25.08% |
| 2024-06-30 | $9.64B | $2.42B | 25.07% |
| 2024-03-31 | $9.56B | $2.36B | 24.67% |
| 2023-12-31 | $9.46B | $2.27B | 23.96% |
| 2023-09-30 | $9.27B | $2.03B | 21.90% |
| 2023-06-30 | $9.09B | $1.89B | 20.80% |
| 2023-03-31 | $8.88B | $1.84B | 20.77% |
| 2022-12-31 | $8.72B | $1.78B | 20.45% |
| 2022-09-30 | $8.70B | $1.94B | 22.33% |
| 2022-06-30 | $8.66B | $1.93B | 22.25% |
| 2022-03-31 | $8.55B | $1.88B | 21.94% |
| 2021-12-31 | $8.29B | $1.80B | 21.71% |
| 2021-09-30 | $8.08B | $1.92B | 23.74% |
| 2021-06-30 | $7.82B | $1.77B | 22.60% |
| 2021-03-31 | $6.92B | $1.23B | 17.70% |
| 2020-12-31 | $6.83B | $1.14B | 16.74% |
| 2020-09-30 | $6.81B | $0.90B | 13.16% |
| 2020-06-30 | $6.84B | $0.95B | 13.84% |
| 2020-03-31 | $7.53B | $1.32B | 17.55% |
| 2019-12-31 | $7.51B | $1.27B | 16.90% |
| 2019-06-30 | $5.49B | $1.00B | 18.15% |
| 2019-03-31 | $5.41B | $0.73B | 13.43% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $43.544B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $194.768B | 85.31 |
| Thermo Fisher Scientific (TMO) | United States | $153.059B | 18.51 |
| Edwards Lifesciences (EW) | United States | $45.878B | 30.08 |
| IDEXX Laboratories (IDXX) | United States | $43.134B | 49.57 |
| DexCom (DXCM) | United States | $34.227B | 52.90 |
| IQVIA Holdings (IQV) | United States | $27.263B | 15.27 |
| Mettler-Toledo (MTD) | United States | $24.414B | 29.03 |
| STERIS (STE) | Ireland | $23.631B | 26.03 |
| Waters (WAT) | United States | $20.771B | 29.31 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.802B | 0.00 |
| Hologic (HOLX) | United States | $14.521B | 15.78 |
| Sysmex ADR (SSMXY) | Japan | $10.950B | 31.06 |
| Penumbra (PEN) | United States | $9.938B | 78.00 |
| Masimo (MASI) | United States | $9.121B | 33.64 |
| Globus Medical (GMED) | United States | $7.990B | 19.04 |
| Glaukos (GKOS) | United States | $5.902B | 0.00 |
| Teleflex (TFX) | United States | $5.230B | 8.63 |
| TransMedics (TMDX) | United States | $4.533B | 98.54 |
| Integer Holdings (ITGR) | United States | $4.291B | 22.48 |
| PROCEPT BioRobotics (PRCT) | United States | $3.187B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.455B | 14.62 |
| Veracyte (VCYT) | United States | $2.117B | 29.70 |
| Nihon Kohden (NHNKY) | Japan | $2.022B | 23.20 |
| Elekta AB (EKTAY) | Sweden | $1.947B | 17.50 |
| Alphatec Holdings (ATEC) | United States | $1.623B | 0.00 |
| Artivion (AORT) | United States | $1.328B | 124.40 |
| Tandem Diabetes Care (TNDM) | United States | $1.242B | 0.00 |
| OPKO Health (OPK) | United States | $1.047B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.015B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.954B | 5.07 |
| SiBone (SIBN) | United States | $0.802B | 0.00 |
| IRadimed (IRMD) | United States | $0.760B | 38.57 |
| Beta Bionics (BBNX) | United States | $0.631B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.566B | 8.81 |
| RxSight (RXST) | United States | $0.528B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.522B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.514B | 12.05 |
| AxoGen (AXGN) | United States | $0.494B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.474B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.437B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.432B | 11.50 |
| AngioDynamics (ANGO) | United States | $0.403B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.372B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.370B | 0.00 |
| NeuroPace (NPCE) | United States | $0.365B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.334B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.265B | 0.00 |
| 908 Devices (MASS) | United States | $0.256B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.28 |
| Neuronetics (STIM) | United States | $0.230B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.214B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.195B | 0.00 |
| Inogen (INGN) | United States | $0.189B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.172B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.141B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.124B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.40 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | United States | $0.070B | 0.00 |
| Spectral AI (MDAI) | United States | $0.063B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.062B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.024B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.33 |